Literature DB >> 33896947

Flaviu Mosora1, Myriam Guèvremont2, Gabriel Vézina1, Karine Côté2, Marianne Boulé3, Denis Lebel4, Jean-François Bussières5, Marie-Élaine Métras3.   

Abstract

BACKGROUND: The pharmacist's role within the multidisciplinary team is often poorly understood. Various interventions can be put into place to promote the role of the pharmacist in the hospital setting with families, patients, and other health care professionals. Few studies have described the feasibility and assessed the impact of such interventions, particularly in pediatrics.
OBJECTIVES: To describe the implementation of a 3-part intervention aimed at increasing the visibility of pharmacists and their role on the treatment team, with the goal of optimizing the pharmaceutical care of hospitalized patients in the general pediatric units of CHU Sainte-Justine, in Montréal, Quebec, and to compare the perceptions and satisfaction of patients' parents and of health care professionals with exposure to either usual pharmaceutical care or to pharmaceutical care incorporating the intervention.
METHODS: This single-blind, randomized, controlled experimental study involved patients admitted to general pediatric units between March 5 and August 8, 2019. In addition to usual care, the intervention included delivery of an information brochure about pharmaceutical services and care, access to a telephone line (which allowed families and patients to contact a pharmacy resident during their stay in hospital and up to 1 month after discharge), and completion of a standardized discharge form by the pharmacist responsible for the patient. The participants and health professionals concerned were surveyed to determine their perceptions and level of satisfaction.
RESULTS: A total of 641 participants were included in the study, 321 in the intervention group and 320 in the control group. The brochure was given to all parents in the intervention group. Twelve phone calls were made through the dedicated telephone line. The standardized discharge form was completed for 46.7% (150/321) of the participants in the intervention group. Most of the parents and patients who responded to the survey, in either group (81.2%, 298/367), reported satisfaction with the pharmaceutical services and care received. Of participants in the intervention group, 83.9% were satisfied with the pharmaceutical care and services received, compared with 78.5% of those in the control group (p = 0.18). In addition, 60.3% (111/184) of participants in the intervention group said that the information about medications that was provided during the hospital stay gave them new knowledge, compared with 48.1% (87/181) of those in the control group (p = 0.019). The results of the survey showed that care providers were in agreement with the intervention.
CONCLUSIONS: The 3 components of the intervention were implemented in the pediatric units over a period of 5 months. The intervention was perceived as positive by the parents and care providers concerned, and the respondents were mostly satisfied with the services and pharmaceutical care offered. 2021 Canadian Society of Hospital Pharmacists. All content in the Canadian Journal of Hospital Pharmacy is copyrighted by the Canadian Society of Hospital Pharmacy. In submitting their manuscripts, the authors transfer, assign, and otherwise convey all copyright ownership to CSHP.

Entities:  

Keywords:  information brochure; pharmacist; standardized discharge form; telephone line

Year:  2021        PMID: 33896947      PMCID: PMC8042187     

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN: 0008-4123


  12 in total

1.  Facilitating Home Hospice Transitions of Care in Oncology: Evaluation of Clinical Pharmacists' Interventions, Hospice Program Satisfaction, and Patient Representation Rates.

Authors:  Alison P Duffy; Nina M Bemben; Jueli Li; James Trovato
Journal:  Am J Hosp Palliat Care       Date:  2018-04-05       Impact factor: 2.500

2.  [Not Available].

Authors:  Bruce Millin
Journal:  Can J Hosp Pharm       Date:  2015 Mar-Apr

3.  The invisible white coat: awareness of pharmacists in a neonatal intensive care unit.

Authors:  Rehana Bajwa; Jennifer G Kendrick; Roxane Carr
Journal:  Can J Hosp Pharm       Date:  2014-07

4.  Improving quality of care in patients with decompensated acute heart failure using a discharge checklist.

Authors:  Damien Legallois; Laure Chaufourier; Katrien Blanchart; Jean-Jacques Parienti; Annette Belin; Paul Milliez; Rémi Sabatier
Journal:  Arch Cardiovasc Dis       Date:  2019-07-25       Impact factor: 2.340

5.  Standardizing Key Issues from Hospital Through an Electronic Multi-Professional Discharge Checklist to Ensure Continuity of Care.

Authors:  Anne Kuusisto; Anne Joensuu; Minna Nevalainen; Terhi Pakkanen; Paula Ranne; Juha Puustinen
Journal:  Stud Health Technol Inform       Date:  2019-08-21

6.  Impact of pharmacists' interventions on the pediatric discharge medication process.

Authors:  Pierre Voirol; Steven R Kayser; Chi Y Chang; Q Laura Chang; Sharon L Youmans
Journal:  Ann Pharmacother       Date:  2004-08-24       Impact factor: 3.154

7.  Improving Transitional Care: The Role of Handoffs and Discharge Checklists in Hematologic Malignancies.

Authors:  Mariah Prince; Deborah Allen; Sarah Chittenden; Joey Misuraca; Marilyn J Hockenberry
Journal:  Clin J Oncol Nurs       Date:  2019-02-01       Impact factor: 1.027

8.  Evaluation of Pharmacist Intervention on Discharge Medication Reconciliation.

Authors:  Robin Lee; Suzanne Malfair; Jordan Schneider; Sukjinder Sidhu; Caitlin Lang; Nina Bredenkamp; Shu Fei Sophie Liang; Alice Hou; Adil Virani
Journal:  Can J Hosp Pharm       Date:  2018-04-30

Review 9.  Interdisciplinary Educational Checklist for Allogeneic Stem Cell Transplant Patients.

Authors:  Jean A Ridgeway
Journal:  J Adv Pract Oncol       Date:  2018-09-01

10.  Accuracy of Inpatient Recall of Interaction With a Pharmacist: A Validation Study From 2 Acute Care Teaching Hospitals.

Authors:  Vaninder K Sidhu; Lauren Bresee; Kyle Kemp; Sheri Koshman; Taciana Pereira; Sheena Neilson
Journal:  J Patient Exp       Date:  2018-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.